Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.
J Clin Neurol. 2017 Sep 27;
Authors: Garnero M, Fabbri S, Gemelli C, Benedetti L, Mancardi GL, Schenone A, Grandis M
PMID: 29141277 [PubMed - as supplied by publisher]

Source: Journal of Clinical Neurology - November 17, 2017 Category: Neurology Tags: J Clin Neurol Source Type: research